ESLA
Price
$0.94
Change
+$0.13 (+16.05%)
Updated
Apr 3, 04:44 PM (EDT)
Capitalization
27.49M
IMUX
Price
$1.04
Change
-$0.07 (-6.31%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
99.99M
35 days until earnings call
Ad is loading...

ESLA vs IMUX

Header iconESLA vs IMUX Comparison
Open Charts ESLA vs IMUXBanner chart's image
Estrella Immunopharma
Price$0.94
Change+$0.13 (+16.05%)
Volume$100
Capitalization27.49M
Immunic
Price$1.04
Change-$0.07 (-6.31%)
Volume$4.79K
Capitalization99.99M
ESLA vs IMUX Comparison Chart
Loading...
ESLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMUX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ESLA vs. IMUX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ESLA is a Hold and IMUX is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (ESLA: $0.81 vs. IMUX: $1.11)
Brand notoriety: ESLA and IMUX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ESLA: 52% vs. IMUX: 98%
Market capitalization -- ESLA: $29.33M vs. IMUX: $93.76M
ESLA [@Biotechnology] is valued at $29.33M. IMUX’s [@Biotechnology] market capitalization is $93.76M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ESLA’s FA Score shows that 0 FA rating(s) are green whileIMUX’s FA Score has 0 green FA rating(s).

  • ESLA’s FA Score: 0 green, 5 red.
  • IMUX’s FA Score: 0 green, 5 red.
According to our system of comparison, IMUX is a better buy in the long-term than ESLA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ESLA’s TA Score shows that 4 TA indicator(s) are bullish while IMUX’s TA Score has 3 bullish TA indicator(s).

  • ESLA’s TA Score: 4 bullish, 6 bearish.
  • IMUX’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, both ESLA and IMUX are a bad buy in the short-term.

Price Growth

ESLA (@Biotechnology) experienced а -17.24% price change this week, while IMUX (@Biotechnology) price change was -7.50% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.57%. For the same industry, the average monthly price growth was -10.69%, and the average quarterly price growth was -14.76%.

Reported Earning Dates

ESLA is expected to report earnings on Mar 14, 2023.

IMUX is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-8.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMUX($100M) has a higher market cap than ESLA($27.5M). IMUX YTD gains are higher at: 11.000 vs. ESLA (-32.417). ESLA has higher annual earnings (EBITDA): -8.82M vs. IMUX (-95.68M). IMUX has more cash in the bank: 59.1M vs. ESLA (1.8M). ESLA (0) and IMUX (0) have equivalent revenues.
ESLAIMUXESLA / IMUX
Capitalization27.5M100M28%
EBITDA-8.82M-95.68M9%
Gain YTD-32.41711.000-295%
P/E RatioN/AN/A-
Revenue00-
Total Cash1.8M59.1M3%
Total DebtN/A899K-
FUNDAMENTALS RATINGS
IMUX: Fundamental Ratings
IMUX
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ESLAIMUX
RSI
ODDS (%)
Bullish Trend 2 days ago
64%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
57%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
54%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
43%
Bearish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
63%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 23 days ago
75%
Bullish Trend 10 days ago
87%
Declines
ODDS (%)
Bearish Trend 7 days ago
85%
Bearish Trend 3 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
80%
N/A
View a ticker or compare two or three
Ad is loading...
ESLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMUX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CGLCF0.150.01
+3.51%
Cassiar Gold Corp.
IBDSF16.730.39
+2.39%
Iberdrola S.A.
COVTY31.820.25
+0.79%
Covestro AG
HELFY2.06N/A
N/A
Hellofresh SE
SDVKY21.04-0.08
-0.38%
Sandvik AB

ESLA and

Correlation & Price change

A.I.dvisor tells us that ESLA and IONS have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ESLA and IONS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ESLA
1D Price
Change %
ESLA100%
+6.71%
IONS - ESLA
28%
Poorly correlated
+5.32%
IMUX - ESLA
25%
Poorly correlated
+4.23%
CARM - ESLA
25%
Poorly correlated
-3.60%
WINT - ESLA
25%
Poorly correlated
+15.83%
CYTOF - ESLA
23%
Poorly correlated
-2.85%
More

IMUX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMUX has been loosely correlated with IPSC. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if IMUX jumps, then IPSC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMUX
1D Price
Change %
IMUX100%
+4.23%
IPSC - IMUX
41%
Loosely correlated
+3.96%
VERV - IMUX
40%
Loosely correlated
-5.44%
NTLA - IMUX
39%
Loosely correlated
+9.69%
CRSP - IMUX
39%
Loosely correlated
+3.17%
LYEL - IMUX
38%
Loosely correlated
+4.79%
More